CN107385057B - RPA-IAC primer and method for detecting vibrio cholerae - Google Patents
RPA-IAC primer and method for detecting vibrio cholerae Download PDFInfo
- Publication number
- CN107385057B CN107385057B CN201710682435.2A CN201710682435A CN107385057B CN 107385057 B CN107385057 B CN 107385057B CN 201710682435 A CN201710682435 A CN 201710682435A CN 107385057 B CN107385057 B CN 107385057B
- Authority
- CN
- China
- Prior art keywords
- amplification
- rpa
- vibrio cholerae
- iac
- internal standard
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides a primer pair and an internal standard amplification sequence, wherein the primer pair comprises SEQ ID NO: 1 and the nucleotide sequence shown in SEQ ID NO: 2, wherein the internal standard amplification sequence comprises a nucleotide sequence shown in SEQ ID NO: 3. The invention also provides the application of the primer pair and the internal standard amplification sequence in the preparation of products for detecting or assisting in detecting vibrio cholerae; and a method for detecting vibrio cholerae based on the RPA-IAC technology. Experiments prove that the RPA-IAC primer has good specificity, high sensitivity, short detection time, no need of special instruments and wide application range, and the RPA-IAC detection method of vibrio cholerae based on the primer and matched with the amplification internal standard is sensitive, accurate, simple, convenient and quick, and has guiding significance for quarantine of import and export related goods and products.
Description
Technical Field
The invention relates to the field of biological detection, in particular to a method, a primer and a kit for detecting vibrio cholerae.
Background
The vibrio cholerae is a gram-negative facultative anaerobe, is widely distributed in shellfish such as oysters, shrimps, crabs and the like and shellfish aquatic animals, and is one of the food-borne pathogenic bacteria with the highest epidemic degree and harm degree. Human beings are the only susceptible people of vibrio cholerae under natural conditions, and are mainly infected by polluted water sources or food through oral administration, and the clinical manifestations of severe vomiting, diarrhea, water loss and high mortality are high. Since 1817 years, seven global pandemic reports of cholera have been reported historically, causing millions of deaths, so cholera is an international quarantine infectious disease and is also classified as a class a infectious disease in our country. China has more cholera in south China, and a great deal of manpower and material resources need to be invested each year for prevention and control, so the detection of the vibrio cholerae has very important significance on public health.
At present, the detection of vibrio cholerae still mainly depends on the traditional method, namely, the selective culture medium is firstly used for enrichment, and then biochemical and serological methods are combined for identification. The traditional method has accurate detection result, but has the defects of low detection efficiency, single detection target, low sensitivity, long time consumption, fussy operation and the like. In order to meet the requirement of rapid detection of pathogenic bacteria, enzyme linked fluorescence immunoassay (VIDAS-CHL), Enzyme Immunoassay (EIA), Polymerase Chain Reaction (PCR), colloidal gold test strip method, API biochemical identification test strip method, loop-mediated isothermal amplification (LAMP) technology, real-time fluorescence PCR and other methods are developed. The VIDAS-CHL method, the EIA method, the colloidal gold test paper method and the API method have the defects of poor specificity, low sensitivity and the like, and are not widely applied; the LAMP method, as a new detection method, has high false positive rate although the detection efficiency is greatly improved and the detection cost is reduced. As a highly sensitive, rapid and simple detection method, the PCR technology is widely applied in a plurality of fields, especially, a revolutionary achievement is obtained in the aspect of pathogen detection, the PCR technology becomes a gold standard for rapid detection of nucleic acid, and on the basis, a DNA probe technology, a real-time fluorescence PCR technology, a PCR combined Denaturation High Performance Liquid Chromatography (DHPLC) technology and the like are developed, the design of a PCR primer is a key factor for restricting the success or failure of the detection method, the conventional PCR primer design not only needs to repeatedly compare the specificity of the primer, but also needs to optimize various parameters and reaction conditions of the primer, especially the annealing temperature, so as to prevent non-specific amplification, and the selected primer is easy to influence the effectiveness and specificity of the amplification under the restriction of the conditions. In addition, the fluorescent detection equipment is generally high in selling price, and the popularization and application of the detection method are limited to a certain extent.
Disclosure of Invention
The invention aims to solve the technical problem of providing a sensitive, accurate, simple, convenient and quick method for detecting vibrio cholerae based on an RPA-IAC technology, and also provides an RPA primer, an internal standard amplification sequence and a corresponding detection kit which are used for the method, have good specificity, high sensitivity, short detection time, no need of special instruments and wide application range.
In order to solve the technical problems, the invention is realized by the following technical scheme:
in a first aspect of the invention, there is provided a primer pair comprising SEQ ID NO: 1 and the nucleotide sequence shown in SEQ ID NO: 2, wherein the internal standard amplification fragment comprises a nucleotide sequence shown in SEQ ID NO: 3.
The second aspect of the invention provides the application of the primer pair and the internal standard amplification sequence in the preparation of products for detecting or assisting in detecting vibrio cholerae;
in a preferred embodiment, the product for preparing the product for detecting or assisting in detecting the vibrio cholerae comprises: preparing a product for detecting or assisting in detecting whether the biological sample is infected with the vibrio cholerae, and preparing a product for detecting or assisting in detecting whether the pathogenic bacteria are or are candidates for being the vibrio cholerae.
In a third aspect, the invention provides a kit comprising the primer pair and a plasmid containing the internal standard amplification sequence.
In a preferred embodiment, the kit further comprises an RPA isothermal amplification reagent.
In a preferred example, the RPA isothermal amplification reagent comprises reagents contained in a TwistAmp Basic kit of an RPA amplification kit from TwistDX.
In a preferred embodiment, the kit further comprises a DNA extraction reagent.
In a preferred embodiment, the DNA extraction reagent comprises a reagent contained in an animal genome DNA extraction kit with the product number DP432 from Tiangen Biochemical technology, Inc.
In a preferred embodiment, the DNA extraction reagent further comprises a reagent contained in a bacterial genomic DNA extraction kit with the product number DP302 from Tiangen Biochemical technology, Inc.
In a preferred embodiment, a positive control and a negative control are also included.
The fourth aspect of the invention provides the application of the kit in detecting or assisting in detecting vibrio cholerae or preparing products for detecting or assisting in detecting vibrio cholerae.
In a preferred embodiment, the detecting or auxiliary detecting of vibrio cholerae comprises: detecting or assisting in detecting whether the biological sample is infected with Vibrio cholerae, and detecting or assisting in detecting whether the pathogenic bacteria is or is a candidate for Vibrio cholerae.
In a preferred embodiment, the product for preparing the product for detecting or assisting in detecting the vibrio cholerae comprises: preparing a product for detecting or assisting in detecting whether the biological sample is infected with the vibrio cholerae, and preparing a product for detecting or assisting in detecting whether the pathogenic bacteria are or are candidates for being the vibrio cholerae.
The fifth aspect of the invention provides an RPA-IAC method for detecting or assisting in detecting vibrio cholerae, which comprises the steps of using the primer pair and a plasmid containing the internal standard amplification sequence or the kit.
In a preferred embodiment, the detecting or auxiliary detecting of vibrio cholerae comprises: detecting or assisting in detecting whether the biological sample is infected with Vibrio cholerae, and detecting or assisting in detecting whether the pathogenic bacteria is or is a candidate for Vibrio cholerae.
In a preferred embodiment, the method comprises the following steps:
1) RPA-IAC amplification
And (3) carrying out RPA amplification by using DNA contained in a biological sample or pathogenic bacteria as a template, the primer pair and the plasmid containing the internal standard amplification sequence or the kit.
2) And judging whether the biological sample is infected with the vibrio cholerae or whether the pathogenic bacteria is or is candidate to be the vibrio cholerae according to the RPA-IAC amplification result.
Optionally, step 1) is preceded by a step of extracting DNA from the biological sample or the pathogenic bacteria.
In a preferred embodiment, the extraction of DNA from the biological sample or the pathogenic bacteria is performed by using an animal genome DNA extraction kit of Tiangen Biochemical technology Co., Ltd, the product number of DP432, or a bacterial genome DNA extraction kit of Tiangen Biochemical technology Co., Ltd, the product number of DP 302.
In a preferred embodiment, the criteria for determining the result of RPA-IAC amplification are:
if the amplification product obtained by the RPA-IAC amplification only has a target gene fragment with the size of 280bp, or simultaneously has an internal standard amplification fragment and a target gene fragment with the sizes of 337bp and 280bp, the biological sample is judged to be infected with vibrio cholerae, or the pathogenic bacteria is or is a candidate of vibrio cholerae; if the amplification product obtained by RPA amplification only has an internal standard amplification fragment with the size of 337bp and does not contain a target gene fragment with the size of 280bp, the biological sample is judged not to be infected with vibrio cholerae, or the pathogenic bacteria is not or is not a candidate of vibrio cholerae; if the amplification product obtained by RPA amplification does not contain the internal standard amplification fragment with the size of 337bp and does not contain the target gene fragment with the size of 280bp, the reaction is judged to be false negative, and detection needs to be carried out again.
In a preferred embodiment, the reaction system for amplifying the RPA-IAC is as follows:
0.2mL twist Amp reaction tube containing freeze-dried enzyme powder
Rehydration buffer 29.5. mu.L
SEQ ID NO: 1 and SEQ ID NO: 2. mu.L of each primer shown in 2, the final concentration of each primer was 0.4. mu. mol/L
Comprises SEQ ID NO: 3 plasmid 1.81X 10 of internal standard amplification sequence3copies
Template DNA 50ng
Magnesium acetate solution 2.5 μ L with concentration of 280mmol/L
Supplementing deionized water to 50 mu L;
in a preferred embodiment, the reaction conditions for the amplification of the RPA-IAC are as follows: the temperature of the RPA-IAC amplification is 37 ℃, and the time is 40 min.
The sixth aspect of the present invention provides a system for screening vibrio cholerae, comprising:
a nucleic acid extraction device for extracting a nucleic acid sample from the biological sample or pathogenic bacteria;
the RPA-IAC amplification device is connected with the nucleic acid extraction device and is suitable for carrying out RPA-IAC amplification on the nucleic acid sample by the primer pair or the kit;
and the judging device is connected with the RPA-IAC amplification device so as to judge whether the biological sample is infected by vibrio cholerae or whether the pathogenic bacteria is or is a candidate of vibrio cholerae based on the result of RPA-IAC amplification.
In a preferred embodiment, the reaction system for amplifying the RPA-IAC is as follows:
0.2mL twist Amp reaction tube containing freeze-dried enzyme powder
Rehydration buffer 29.5. mu.L
SEQ ID NO: 1 and SEQ ID NO: 2. mu.L of each primer shown in 2, the final concentration of each primer was 0.4. mu. mol/L
Comprises SEQ ID NO: 3 internal standard amplification sequence of 1.81X 103copies
Template DNA 50ng
Magnesium acetate solution 2.5 μ L with concentration of 280mmol/L
Supplementing deionized water to 50 mu L;
optionally, the reaction conditions for the RPA-IAC amplification are as follows: the temperature of the RPA-IAC amplification is 37 ℃, and the time is 40 min.
The biological sample of the present invention is blood, cells, tissues, etc., or food in which blood, cells, tissues, etc. are mixed, etc.; the pathogenic bacteria is a pure strain or a mixture of at least two strains.
The internal standard amplification fragment is a section of artificially constructed DNA sequence or a section of conservative gene sequence of pathogenic bacteria which is added into a PCR reaction system to indicate false negative phenomenon. The main principle of the internal amplification standard is as follows: adding the amplification internal standard into a PCR reaction system to amplify together with the target gene, and if some inhibiting factors exist in the reaction system, inhibiting the amplification reactions of the amplification internal standard and the target gene so as to achieve the purpose of indicating the false negative of the PCR reaction.
The beneficial effects of the invention include:
(1) the invention designs specific RPA-IAC primers aiming at the vibrio cholerae, establishes a vibrio cholerae RPA-IAC detection method, and can carry out qualitative detection on the vibrio cholerae.
(2) The amplification internal standard sequence is not homologous with the vibrio cholerae genome and the human genome, so that the amplification efficiency of a target sequence is ensured, and false negative detection and individual nucleic acid interference detection of operators are effectively avoided; .
(3) The invention only designs a pair of primers aiming at the vibrio cholerae to complete the amplification, thereby saving the complicated primer design process; the primer amplification of the invention only needs constant temperature reaction at 37 ℃, and does not need special thermal cycle equipment; the reaction time is only 40min, and the detection time is short; unlike the diffuse band of LAMP product, the RPA-IAC amplification product has a band with a specific size according to the designed site of the primer, and the result is easy to judge.
(4) The RPA-IAC amplification primer has good specificity, high sensitivity and wide application range.
(5) The method for detecting the vibrio cholerae RPA-IAC is sensitive, accurate, simple, convenient and quick, and has guiding significance for inspection and quarantine of related goods and products for import and export.
Drawings
FIG. 1 shows the result of the electrophoresis detection of the specificity test of the RPA-IAC primer pair in example 4 of the present invention. Wherein M is marker DL1000, 1: vibrio cholerae; 2: vibrio fluvialis; 3: vibrio parahaemolyticus; 4: vibrio mimicus; 5: vibrio alginolyticus; 6: vibrio vulnificus; 7: vibrio harveyi; 8: salmonella; 9: e.coli; 10: staphylococcus aureus bacteria; 11: listeria monocytogenes.
FIG. 2 shows the results of the electrophoretic detection of the sensitivity assay for RPA-IAC amplification in example 5 of the present invention. Wherein M is marker DL1000, 1-6: the amount of Vibrio cholerae template is 100ng, 10ng, 1ng, 0.1ng, 0.01ng and 0.001ng in sequence, and the amount of amplification internal standard is 1.81 × 103copies。
FIG. 3 shows the results of the electrophoresis of the sensitivity test for RPA amplification in example 5 of the present invention. Wherein M is marker DL1000, 1-6: the amount of Vibrio cholerae template is 100ng, 10ng, 1ng, 0.1ng, 0.01ng and 0.001ng in sequence.
Detailed Description
Unless otherwise defined, the terms used herein have the ordinary meanings as commonly understood in the art to which this invention belongs.
The present invention will now be described with reference to specific examples and figures, which are provided for illustrative purposes only and are not to be construed as limiting the invention. The specific techniques or conditions are not specified in the examples and are generally performed according to conventional experimental conditions, such as the Molecular cloning handbook, Sambrook et al (Sambrook J & Russell DW, Molecular cloning: a laboratory Manual,2001), or according to the manufacturer's instructions. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available.
Vibrio parahaemolyticus, Vibrio cholerae, Vibrio alginolyticus, Vibrio vulnificus, Vibrio mimicus, Vibrio fluvialis, Vibrio harveyi, Escherichia coli, Staphylococcus aureus, Salmonella, and Listeria monocytogenes used in the following examples are provided by the Shantou export-import inspection and quarantine office.
Example 1
This example provides RPA primer pairs and internal standard amplification sequences and uses thereof.
The screening method of the RPA primer pair comprises the following steps: aiming at vibrio cholerae owpW gene (GenBank ID: CP013316.1), a plurality of RPA primers are designed and screened in a large quantity, the specificity, the sensitivity, the functions between the primers and the suitability of each primer and an RPA amplification kit are synthesized, and the following RPA primer pairs which have good specificity, good repeatability and high sensitivity and can detect vibrio cholerae are screened finally:
owpW-F：5′-GAAGGTGACTTTATTGTGCGCGCGGGTATTGCC-3′(SEQ ID NO：1)；
owpW-R：5′-CACCAAAGTAGTATTGGACCATAAAGGTAGGT-3′(SEQ ID NO：2)；
design and synthesis of internal standard amplification sequence: in order to avoid homologous interference of similar bacteria and individual nucleic acid pollution of detection personnel, by comprehensive analysis and consideration, on the basis of a partial nucleic acid sequence of a highly conserved porcine species-specific gene beta-actin, two ends of the nucleic acid sequence are respectively connected with primer sequences owpW-F and owpW-R to form an internal standard amplification sequence with the sequence size of 337bp as shown below:
GAAGGTGACTTTATTGTGCGCGCGGGTATTGCCgttcgagaccttcaacaccccagccatgtacgtggccatccaggcggtgctgtccctgtacgcctctggccgcaccactggcatcgtgatggactccggagacggggtcacccacacggtgcccatctacgaggggtacgccctgccccacgccatcctgcgtctggacctggctggccgggacctgaccgactacctcatgaagatcctgacggagcggggctacagcttcaccaccacggccgagcgggagatcgtgcgggacatcaaggACCTACCTTTATGGTCCAATACTACTTTGGTG(Seq ID NO：3)
the above Seq ID NO: in 3, the upper case sequence is the original sequence of the added owpW-F and the reverse complement sequence of the owpW-R, the lower case sequence 272bp is derived from a section of sequence with Genbank accession number DQ452569.1 and the title of Sus scrofa beta Act (ACTB) gene, 489-.
The synthesis of the RPA-IAC primer pair and the internal standard amplification sequence is completed by Shanghai Biotechnology Limited company.
In application, the primer pair and the internal standard amplification sequence can be applied to the preparation of products for detecting or assisting in detecting vibrio cholerae, for example, the internal standard amplification sequence is prepared into a plasmid containing the internal standard amplification sequence, and then the internal standard amplification sequence is combined with the primer pair or other products for detecting or assisting in detecting vibrio cholerae to directly detect or assist in detecting whether a biological sample is infected with vibrio cholerae.
Example 2
This embodiment provides a kit and its application, the kit includes:
(1) SEQ ID NO: 1. SEQ ID NO: 2 (from example 1), and a polypeptide comprising the sequence set forth in SEQ ID NO: 3, a plasmid of an internal standard amplification sequence;
(2) DNA extraction reagent;
(3) a tube containing lyophilized enzyme powder;
(4) rehydrating the buffer;
(5) and (3) magnesium acetate solution.
The lyophilized enzyme-containing powder tube, Rehydration Buffer (Rehydration Buffer), and magnesium acetate solution (280mmol/L) were reagents from the RPA amplification KIT twist Basic KITs (twist DX, Cat. TABAS03 KIT).
The DNA extraction reagent is a reagent in an animal genome DNA extraction kit from Tiangen Biochemical technology Co., Ltd, the commodity number of DP432, and a reagent contained in a bacterial genome DNA extraction kit from Tiangen Biochemical technology Co., Ltd, the commodity number of DP 302.
The polypeptide containing the amino acid sequence shown in SEQ ID NO: 3, construction of plasmids of internal standard amplification sequences: the internal amplification sequence synthesized in example 1 was ligated to the universal vector PUC57 to yield a nucleic acid sequence containing the sequence shown in SEQ ID no: 3, and (3) a positive plasmid of an internal standard amplification sequence.
The construction work of the internal standard amplification sequence plasmid is realized by Shanghai Biotechnology company Limited by adopting the conventional T4 bacteriophage DNA ligase to connect to the universal vector PUC57 and preparing the positive plasmid freeze-dried powder. According to the copy number of N copies/. mu.L ═ PCR fragment mass (g/. mu.L)/(650 g/mol. times.base number) × (6.02X 10)23) Calculating, diluting the positive plasmid dry powder to 1.81X 103copies/μL
Using SEQ ID NO: 1. SEQ ID NO: 2 and the above peptide having the sequence shown in SEQ ID NO: 3, carrying out RPA-IAC amplification on the plasmid of the internal standard amplification sequence aiming at the vibrio cholerae, wherein the sizes of the obtained RPA-IAC target gene amplification product and the amplification internal standard product are respectively 280bp and 337 bp.
Experiments prove that the DNA extraction reagent, the tube containing freeze-dried enzyme powder, the rehydration buffer solution and the magnesium acetate solution, and the DNA extraction reagent containing the DNA extraction reagent and the rehydration buffer solution are mixed with the DNA extraction reagent of SEQ ID NO: 1. SEQ ID NO: 2 and a polypeptide comprising the amino acid sequence as set forth in SEQ ID NO: 3, the effect is more superior by the combined use of the plasmids of the internal standard amplification sequence, which is particularly shown in strong specificity, good repeatability, high sensitivity and good quality control effect.
In application, the kit can be applied to detection or auxiliary detection of vibrio cholerae, for example, detection or auxiliary detection of whether a biological sample is infected with vibrio cholerae or detection or auxiliary detection of whether a biological sample to be detected is or is candidate for vibrio cholerae; the method can also be used for preparing products for detecting or assisting in detecting the vibrio cholerae, for example, preparing products for detecting or assisting in detecting whether a biological sample is infected with the vibrio cholerae or preparing products for detecting or assisting in detecting pathogenic bacteria as or as candidates for the vibrio cholerae.
Example 3
This example provides a method for detecting or aiding in the detection of Vibrio cholerae, such as detecting or aiding in the detection of whether a biological sample is infected with Vibrio cholerae, or detecting or aiding in the detection of whether a pathogen is or is a candidate for Vibrio cholerae, using the primer pair of example 1 or the kit of example 2.
The method comprises the following steps:
the method comprises the following steps: RPA-IAC amplification
Adding the DNA of a biological sample or pathogenic bacteria as a template into the DNA containing the DNA shown in SEQ ID NO: 3, adopting the plasmid of an internal standard amplification sequence shown in SEQ ID NO: 1 and SEQ ID NO: 2 to obtain an RPA-IAC amplification product, and setting a blank control (the template is ultrapure water).
The preparation method of the RPA-IAC amplification system comprises the following steps: to a 0.2mL twist Amp reaction tube containing lyophilized enzyme powder was added 29.5. mu.L of Rehydration Buffer (Rehydration Buffer), 2. mu.L each of the upstream and downstream primers (owpW-F and owpW-R of example 1) (final concentration of each primer was 0.4. mu. mol/L) containing the sequence as set forth in SEQ ID NO: 3 plasmid 1. mu.L (1.81X 10) of internal amplification sequence shown in3copies), template DNA1ul (50ng), and finally 2.5. mu.L of magnesium acetate solution (280mmol/L) was added and made up to 50. mu.L with deionized water.
RPA-IAC amplification reaction conditions: and (3) fully and uniformly mixing the RPA-IAC amplification system, and placing the mixture on a metal bath at 37 ℃ for reaction for 40min to obtain an RPA-IAC amplification product.
Step two: electrophoretic detection of RPA-IAC amplification products
After the RPA-IAC reaction is finished, adding 50 mu L of phenol/chloroform (1:1) solution into the amplification product, fully mixing uniformly, centrifuging at 12000rpm for 2min, taking 5 mu L of supernatant to perform electrophoresis on 1.5% agarose gel, observing the result on a gel imaging system, and sequencing the RPA-IAC amplification product (sequencing verification is performed in the establishment process, and the description is omitted).
The standard for judging the result of RPA-IAC amplification is as follows:
if the amplification product obtained by RPA-IAC amplification only has a target gene fragment with the size of 280bp, or simultaneously has an internal standard amplification fragment and a target gene fragment with the sizes of 337bp and 280bp, respectively, the biological sample is judged to contain vibrio cholerae, which prompts the biological sample to infect the vibrio cholerae, or the pathogenic bacteria are or are candidates of the vibrio cholerae; if the amplification product obtained by the RPA-IAC amplification only has an internal standard amplification fragment with the size of 337bp and does not contain a target gene fragment with the size of 280bp, the biological sample is judged to contain no vibrio cholerae, and the biological sample is prompted to be not infected with the vibrio cholerae, or the pathogenic bacteria are not or are not candidates to be the vibrio cholerae; and if the amplification product obtained by RPA-IAC amplification does not contain the internal standard amplification fragment with the size of 337bp and does not contain the target gene fragment with the size of 280bp, judging the reaction as false negative and prompting that the detection needs to be carried out again.
If the plant to be detected or the pathogenic bacteria to be detected has not extracted DNA, the method step (1) of RPA-IAC amplification may further comprise a step of extracting DNA from the biological sample or the pathogenic bacteria to be detected by using an animal genome DNA extraction kit (purchased from Tiangen Biochemical technology Co., Ltd., product number DP432) or a bacterial genome DNA extraction kit (purchased from Tiangen Biochemical technology Co., Ltd., product number DP302) according to the kit instructions.
Example 4
This example verifies the validity and specificity of the primer pair and the internal standard amplification sequence of example 1, and the used test materials are as follows: vibrio parahaemolyticus, Vibrio vulnificus, Vibrio alginolyticus, Vibrio cholerae, Vibrio mimicus, Vibrio fluvialis, Vibrio harveyi, Escherichia coli, Staphylococcus aureus, Salmonella and Listeria monocytogenes, which are standard strains purchased and strictly verified, are all stored in the inspection and quarantine technical center of Shantou entry and exit inspection and quarantine bureau.
The method comprises the following steps: extraction of genomic DNA
The method comprises the steps of respectively extracting the genomic DNA of vibrio parahaemolyticus, vibrio vulnificus, vibrio alginolyticus, vibrio cholerae, vibrio mimicus, vibrio fluvialis, vibrio harveyi, escherichia coli, staphylococcus aureus, salmonella and listeria monocytogenes by adopting a bacterial genomic DNA extraction kit with the product number DP302 of the Beijing Biotechnology (Beijing) Limited company according to a kit specification.
Step two: RPA-IAC amplification
Various genomic DNA templates were used:
Using groups 1 to 11 as templates, RPA-IAC amplification was performed in the same manner as in step one of example 3.
Step three: electrophoretic detection of RPA-IAC amplification products
The method for electrophoretic detection of the RPA-IAC amplification product is the same as the second step of example 3.
And (4) analyzing results:
as shown in FIG. 1, the results of the analysis are shown in groups 1-11, which correspond to lanes 1-11, respectively, lane 1 shows that there are amplified bands at 337bp and 280bp, and the judgment standard of example 3 shows that the samples are positive, i.e., Vibrio cholerae is successfully detected, and the other lanes 2-11 show that there are amplified bands only at 337bp, so that the judgment standard of example 3 eliminates the possibility of false negative, and further improves the reliability of the results. In conclusion, the positive judgment result and the negative judgment result are accurate, and all groups of amplification internal standards are successfully amplified, so that the primer pair and the internal standard amplification sequence in the embodiment 1 have effectiveness, high specificity and good indication property; furthermore, the method for detecting or assisting in detecting the vibrio cholerae, which is established based on the primer pair, the internal standard amplification sequence and the kit, can accurately detect the vibrio cholerae.
Example 5
This example demonstrates the sensitivity of the primer pair and internal standard amplification sequence of example 1 and compares it with the absence of the internal amplification standard (i.e., the absence of the plasmid containing the internal standard amplification sequence shown in SEQ ID NO: 3 in example 2) using the following test materials: vibrio cholerae, which is a standard strain purchased and strictly verified, is stored in the inspection and quarantine technical center of Shantou entry and exit inspection and quarantine bureau.
The method comprises the following steps: extraction of genomic DNA
The method comprises the steps of respectively extracting the genome DNA of vibrio cholerae by adopting a bacterial genome DNA extraction kit with the product number DP302 of Tiangen Biochemical technology (Beijing) Co., Ltd according to the kit specification, and carrying out 10-fold gradient dilution on the obtained genome DNA to prepare the genome DNA of vibrio cholerae with different concentrations.
Step two: RPA amplification and RPA-IAC amplification
Genomic DNA of vibrio cholerae at different concentrations was used as template:
group 1: 100 ng/. mu.L of Vibrio cholerae genomic DNA (1. mu.L) was used as a template.
Group 2: 10 ng/. mu.L of Vibrio cholerae genomic DNA (1. mu.L) was used as a template.
Group 3: 1 ng/. mu.L of Vibrio cholerae genomic DNA (1. mu.L) was used as a template.
Group 4: 0.1 ng/. mu.L of Vibrio cholerae genomic DNA (1. mu.L) was used as a template.
Group 5: 0.01 ng/. mu.L of Vibrio cholerae genomic DNA (1. mu.L) was used as a template.
Group 6: 0.001 ng/. mu.L of Vibrio cholerae genomic DNA (1. mu.L) was used as a template.
Respectively carrying out RPA amplification and RPA-IAC amplification by taking the groups 1 to 6 as templates, wherein the RPA-IAC amplification method is the same as the first step of the example 3, and the difference between the RPA amplification and the RPA-IAC amplification is that the amplification system does not contain the nucleotide sequence shown in SEQ ID NO: 3 internal standard amplification sequence.
Step three: electrophoretic detection of RPA amplification product and RPA-IAC amplification product
The electrophoretic detection method of the amplification products is the same as the second step of example 3.
And (4) analyzing results:
the result of RPA-IAC amplification is shown in FIG. 2, groups 1-4 all have a band at 280bp and groups 2-6 have a band at 337bp, which indicates that the results of groups 1-6 are all valid and groups 5-6 have no false negative possibility, and also indicates that the primer pair of example 1 of the present invention has high sensitivity, and can detect that the sample only contains 0.1ng of trace DNA; the results of RPA amplification are shown in FIG. 3, with sensitivity results similar to that of RPA-IAC amplification. In conclusion, it is clear that the addition of the internal amplification standard does not reduce the sensitivity of the detection.
Comparative example 1
In fact, before seeking the primer pairs of the present invention, the plasmid containing the internal standard amplification sequence of the present invention (from example 2) was tried to be combined with a very large number of primer pairs, and only some of them were extracted and described in this comparative example, and the rest of them are not described again, specifically:
using the Primer pair of example 1 and the Primer pair designed and selected by the Primer Premier 5.0 software, 50 export marine products were tested by the method for testing or assisting in testing Vibrio cholerae established in example 3, and the 50 marine products were tested for Vibrio cholerae separation and systematic biochemical identification by referring to national food hygiene microbiological test standards (GB 4789.7-2013), the sampling and template concentration gradient settings for the sensitivity test were performed as in example 5, and the test results are shown in Table 2.
TABLE 2
The results show that: in view of the fact that the detection result of the primer pair of the invention is completely consistent with the detection results of the reference standard and the disclosed detection method under the condition that the plasmid containing the internal standard amplification sequence exists, the primer pair of the invention has strong specificity, high sensitivity and good repeatability, and the combination of a plurality of primers randomly selected by adopting primer design software has various defects of weak specificity, weak sensitivity, poor repeatability, interference with the internal standard of amplification and the like more or less.
Comparative example 2
This comparative example provides a comparison of the results of detection of Vibrio cholerae using different reagents in combination with the primer pair of the invention (from example 1) and a plasmid containing an internal standard amplification sequence (from example 1).
Various reagents were combined with the primer pairs of the invention and plasmids containing internal standard amplification sequences:
combination 1: the invention relates to a primer pair, a plasmid containing an internal standard amplification sequence, a certain commercially available animal genome DNA extraction kit 1 and a certain commercially available RPA amplification kit 1
And (3) combination 2: the invention relates to a primer pair, a plasmid containing an internal standard amplification sequence, a certain commercially available animal genome DNA extraction kit 2 and a certain commercially available RPA amplification kit 2
And (3) combination: the invention relates to a primer pair, a plasmid containing an internal standard amplification sequence, a certain commercially available animal genome DNA extraction kit 3 and a certain commercially available RPA amplification kit 3
The combination of the invention: the primer pair and the plasmid containing an internal standard amplification sequence + the reagent contained in the animal genome DNA extraction KIT with the product number DP432 from Tiangen Biochemical technology Limited company + the reagent contained in the RPA amplification KIT with the product number TABAS03KIT from TwistDX company are disclosed.
When the combination of the invention is used for detecting vibrio cholerae, the method is carried out by adopting the method in the example 3. The sampling and template concentration gradient settings for the sensitivity assay were performed as in example 5.
When the combination 1, the combination 2 and the combination 3 are used for detecting the vibrio cholerae, the operation is carried out according to the kit specification when the commercially available kit is used, and the other conditions are the same as the combination of the invention. And tested by a standard published comparative method (see comparative example 1).
The test sample was identical to 50 parts of export seafood as in comparative example 1.
The results are shown in Table 3.
TABLE 3
The results show that: the detection result of the combination of the primer pair, the plasmid containing the internal standard amplification sequence and each specific reagent is completely consistent with the detection results of European Union standards and the disclosed detection method, which shows that the kit formed by the combination of the primer pair, the internal standard amplification sequence and each specific reagent has the advantages of strong specificity, high sensitivity and good repeatability, and the combination of the primer pair and other randomly selected reagents has various defects of weak specificity, weak sensitivity and poor repeatability more or less under the condition that the internal standard amplification sequence exists.
Although the invention has been described in detail hereinabove with respect to a general description and specific embodiments thereof, it will be apparent to those skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
SEQUENCE LISTING
<110> inspection and quarantine technology center of Guangdong entry-exit inspection and quarantine bureau; inspection and quarantine technology center of Shantou entry and exit inspection and quarantine bureau
<120> RPA-IAC primer and method for detecting vibrio cholerae
<130> 17CN
<160> 3
<170> PatentIn version 3.3
<210> 1
<211> 33
<212> DNA
<213> Artificial
<220>
<223> SEQ ID NO ：1
<400> 1
gaaggtgact ttattgtgcg cgcgggtatt gcc 33
<210> 2
<211> 32
<212> DNA
<213> Artificial
<220>
<223> SEQ ID NO ：2
<400> 2
caccaaagta gtattggacc ataaaggtag gt 32
<210> 3
<211> 334
<212> DNA
<213> Artificial
<220>
<223> SEQ ID NO ：3
<400> 3
gaaggtgact ttattgtgcg cgcgggtatt gccgttcgag accttcaaca ccccagccat 60
gtacgtggcc atccaggcgg tgctgtccct gtacgcctct ggccgcacca ctggcatcgt 120
gatggactcc ggagacgggg tcacccacac ggtgcccatc tacgaggggt acgccctgcc 180
ccacgccatc ctgcgtctgg acctggctgg ccgggacctg accgactacc tcatgaagat 240
cctgacggag cggggctaca gcttcaccac cacggccgag cgggagatcg tgcgggacat 300
caaggaccta cctttatggt ccaatactac tttggtg 337
Claims (10)
1. A primer pair and an internal standard amplification sequence, wherein the primer pair is SEQ ID NO: 1 and the nucleotide sequence shown in SEQ ID NO: 2, and the internal standard amplification sequence is SEQ ID NO: 3.
2. The primer pair and the internal standard amplification sequence according to claim 1 are applied to preparation of products for detecting or assisting in detecting vibrio cholerae.
3. A kit comprising the primer pair of claim 1 and a plasmid comprising the internal amplification sequence of claim 1.
4. The kit of claim 3, further comprising RPA isothermal amplification reagents.
5. The kit according to claim 4, wherein the RPA isothermal amplification reagent is a reagent contained in the TwistAmp Basic kit of the RPA amplification kit from TwistDX.
6. The kit of claim 4, further comprising a DNA extraction reagent.
7. The kit according to claim 6, wherein the DNA extraction reagent further comprises a reagent contained in a genomic DNA extraction kit from a bacterium having a cargo number DP302 from Tiangen Biochemical technology Ltd.
8. The kit of claim 4, further comprising a positive control and a negative control.
9. Use of the kit according to any one of claims 3 to 8 for the detection or assisted detection of Vibrio cholerae for non-diagnostic purposes, or for the preparation of a product for the detection or assisted detection of Vibrio cholerae.
10. A method for detecting or assisting in detecting RPA-IAC of Vibrio cholerae for non-diagnostic purposes, comprising the steps of:
1) RPA-IAC amplification:
using a DNA contained in a biological sample or a pathogenic bacterium as a template, performing RPA-IAC amplification using the primer set according to claim 1 and a plasmid comprising an internal amplification sequence according to claim 1, or using the kit according to any one of claims 3 to 4;
2) judging whether the biological sample is infected with vibrio cholerae or whether the pathogenic bacteria is or is a candidate of vibrio cholerae according to the result of RPA-IAC amplification;
before the step 1), the method also comprises the step of extracting DNA in a biological sample or pathogenic bacteria;
the standard for judging the result of RPA-IAC amplification is as follows:
if the amplification product obtained by the RPA-IAC amplification only has a target gene fragment with the size of 280bp, or simultaneously has an internal standard amplification fragment and a target gene fragment with the sizes of 337bp and 280bp, the biological sample is judged to be infected with vibrio cholerae, or the pathogenic bacteria is or is a candidate of vibrio cholerae; if the amplification product obtained by the RPA-IAC amplification only has an internal standard amplification fragment with the size of 337bp and does not contain a target gene fragment with the size of 280bp, the biological sample is judged not to be infected by vibrio cholerae, or the pathogenic bacteria is not or the candidate is not vibrio cholerae; if the amplification product obtained by the RPA-IAC amplification does not contain the internal standard amplification fragment with the size of 337bp and does not contain the target gene fragment with the size of 280bp, the reaction is judged to be false negative, and the detection is required to be carried out again;
the reaction system for RPA-IAC amplification is as follows:
a 0.2mL twist Amp reaction tube containing lyophilized enzyme powder; rehydration buffer: 29.5 μ L; SEQ ID NO: 1 and SEQ ID NO: 2, the final concentration of each primer is 0.4 mu mol/L; comprises SEQ ID NO: 3 internal standard amplification sequence: 1.81X 103copies; template DNA: 50 ng; magnesium acetate solution: 2.5 mu L, the concentration is 280 mmol/L; deionized water: make up to 50 μ L;
the reaction conditions for the amplification of the RPA-IAC are as follows: the temperature of the RPA-IAC amplification is 37 ℃, and the time is 40 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710682435.2A CN107385057B (en) | 2017-08-10 | 2017-08-10 | RPA-IAC primer and method for detecting vibrio cholerae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710682435.2A CN107385057B (en) | 2017-08-10 | 2017-08-10 | RPA-IAC primer and method for detecting vibrio cholerae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107385057A CN107385057A (en) | 2017-11-24 |
| CN107385057B true CN107385057B (en) | 2020-11-13 |
Family
ID=60355357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710682435.2A Active CN107385057B (en) | 2017-08-10 | 2017-08-10 | RPA-IAC primer and method for detecting vibrio cholerae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107385057B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113604588A (en) * | 2021-06-17 | 2021-11-05 | 南京晓庄学院 | Method, primer group, colloidal gold test strip and kit for rapidly detecting vibrio cholerae based on MIRA technology |
| CN114507745A (en) * | 2022-03-17 | 2022-05-17 | 广州市微生物研究所有限公司 | RPA-IAC primer for detecting vibrio alginolyticus, kit, application and method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101570783A (en) * | 2009-03-20 | 2009-11-04 | 郑秋月 | Detection kit and detection method for 9 species of pathogenic organisms in marine products |
| CN102382886A (en) * | 2011-11-04 | 2012-03-21 | 中国海洋大学 | Isothermal strand displacement amplification (SDA) quick detection kit and detection method for vibrio cholerae |
| CN102719542A (en) * | 2012-06-19 | 2012-10-10 | 上海仁度生物科技有限公司 | Simultaneous amplification and testing reagent kit for VC (vibrio cholerae) |
| CN103820558A (en) * | 2014-03-03 | 2014-05-28 | 舟山市质量技术监督检测研究院 | Gene chip for detecting nine pathogenicity vibrios in marine products |
| CN105400778A (en) * | 2015-09-25 | 2016-03-16 | 深圳市疾病预防控制中心 | Kit capable of detecting 10 pathogenic vibrios simultaneously and detection method |
| CN106434900A (en) * | 2016-08-30 | 2017-02-22 | 上海生物信息技术研究中心 | Method for conducting rapid constant-temperature detection on vibrio vulnificus and vibrio cholerae simultaneously, primer and kit |
| CN106967816A (en) * | 2017-04-25 | 2017-07-21 | 暨南大学 | Detect the RPA specific primers of vibrio parahaemolytious and kit and application in food |
-
2017
- 2017-08-10 CN CN201710682435.2A patent/CN107385057B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101570783A (en) * | 2009-03-20 | 2009-11-04 | 郑秋月 | Detection kit and detection method for 9 species of pathogenic organisms in marine products |
| CN102382886A (en) * | 2011-11-04 | 2012-03-21 | 中国海洋大学 | Isothermal strand displacement amplification (SDA) quick detection kit and detection method for vibrio cholerae |
| CN102719542A (en) * | 2012-06-19 | 2012-10-10 | 上海仁度生物科技有限公司 | Simultaneous amplification and testing reagent kit for VC (vibrio cholerae) |
| CN103820558A (en) * | 2014-03-03 | 2014-05-28 | 舟山市质量技术监督检测研究院 | Gene chip for detecting nine pathogenicity vibrios in marine products |
| CN105400778A (en) * | 2015-09-25 | 2016-03-16 | 深圳市疾病预防控制中心 | Kit capable of detecting 10 pathogenic vibrios simultaneously and detection method |
| CN106434900A (en) * | 2016-08-30 | 2017-02-22 | 上海生物信息技术研究中心 | Method for conducting rapid constant-temperature detection on vibrio vulnificus and vibrio cholerae simultaneously, primer and kit |
| CN106967816A (en) * | 2017-04-25 | 2017-07-21 | 暨南大学 | Detect the RPA specific primers of vibrio parahaemolytious and kit and application in food |
Non-Patent Citations (2)
| Title |
|---|
| Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control;Zachary A. Crannell等;《Journal of Visualized Experiments》;20150330;第97卷;e52620 * |
| Real-Time Recombinase Polymerase Amplification Assay for the Detection of Vibrio cholerae in Seafood;Yuyi Tang等;《Food Anal. Methods》;20170206;第10卷;表1，表3，图2，第2657页右栏最后1段至第2660页左栏倒数第1段，第2659页左栏最后1段至右栏第1段，第2661页左栏倒数第2段，第2664页左栏第2段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107385057A (en) | 2017-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106967816B (en) | RPA specific primer for detecting vibrio parahaemolyticus in food, kit and application | |
| CN109913565B (en) | Kit, primer pair, probe and method for detecting vibrio parahaemolyticus | |
| CN102864228A (en) | Loop-mediated isothermal amplification (LAMP) kit for rapidly detecting vibrio parahaemolyticus | |
| CN107227377B (en) | RPA-IAC primer and method for detecting vibrio vulnificus | |
| CN110004250A (en) | A kind of African swine fever virus LAMP visual detection kit | |
| CN114075607B (en) | On-site visualization kit for detecting listeria monocytogenes based on SHERLOCK and application | |
| CN111154903A (en) | Primer group for Brucella RPA amplification, visual detection kit and application | |
| CN107385057B (en) | RPA-IAC primer and method for detecting vibrio cholerae | |
| CN110438260B (en) | African swine fever virus nucleic acid test strip detection kit | |
| JP2007274934A (en) | Primer set and method for detecting food poisoning bacterium | |
| CN107227378B (en) | RPA-IAC primer and method for detecting vibrio mimicus | |
| CN108998575B (en) | Establishment of double PCR detection method for chicken parvovirus and chicken newcastle disease virus | |
| CN111004854B (en) | Rapid constant temperature detection method, primer set and kit for vibrio vulnificus and vibrio cholerae simultaneously | |
| CN110592274A (en) | RAA constant temperature fluorescence detection method and reagent for Large Yellow Croaker Iridovirus (LYCIV) | |
| KR102280441B1 (en) | Method for detecting maritime virus, and primer set, composition and kit for the same | |
| CN114507745A (en) | RPA-IAC primer for detecting vibrio alginolyticus, kit, application and method thereof | |
| CN110257560B (en) | Reagent for bluetongue virus type 8 detection, detection method and application | |
| Zhao et al. | An ultra-fast, one-step RNA amplification method for the detection of Salmonella in seafood | |
| CN111996268A (en) | Vibrio alginolyticus double TaqMan probe real-time fluorescent quantitative PCR (polymerase chain reaction) detection kit and preparation method thereof | |
| CN110894551A (en) | RAA constant-temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type I virus (GCRV-I) | |
| CN110205361B (en) | RT-qsCPA primer for detecting vibrio parahaemolyticus as well as kit and method thereof | |
| CN116515840B (en) | Kit and detection method for detecting bovine viral diarrhea virus type 3 | |
| CN110592271A (en) | RAA constant temperature fluorescence detection method and reagent for Infectious Hematopoietic Necrosis Virus (IHNV) | |
| CN111621576B (en) | RPA primer and probe for detecting oil fish and detection method | |
| US20070009910A1 (en) | Primers, probes and reference plasmid for detection of meat adulteration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 510000 B1401, 66 Huacheng Avenue, Pearl River New Town, Tianhe District, Guangzhou City, Guangdong Province Applicant after: Guangzhou Customs Technology Center Applicant after: Shantou Customs Technical Center Address before: 510623, B, 66, Huacheng Avenue, Zhujiang New Town, Guangzhou, Guangdong, Tianhe District Applicant before: INSPECTION & QUARANTINE TECHNOLOGY CENTER OF GUANGDONG ENTRY-EXIT INSPECTION & QUARANTINE BUREAU Applicant before: INSPECTION AND QUARANTINE TECHNOLOGY CENTER OF SHANTOU ENTRY-EXIT INSPECTION AND QUARANTINE BUREAU |
|
| CB02 | Change of applicant information | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |